Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y ▼ | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Viking Therapeutics Inc | 2.550% | 0.679% | -19.051% | 250.351% | 171.204% | 740.482% | - |
| Eli Lilly Corp. | 0.580% | 2.585% | 13.408% | 100.378% | 60.833% | 340.456% | 765.647% |
| Ocular Therapeutix Inc. | 1.710% | 11.244% | 18.070% | 41.082% | 50.429% | -48.683% | 61.474% |
| Novo Nordisk A/S ADR | -0.740% | 2.652% | 9.274% | -4.912% | 44.456% | 95.245% | 202.455% |
| G1 Therapeutics | 6.910% | -10.980% | -44.025% | -12.167% | -23.345% | -89.492% | - |
| Align Technology | 0.130% | 0.177% | -3.976% | -26.963% | -9.200% | -55.922% | -4.782% |
| Evotec SE | 3.230% | 0.354% | -7.846% | -57.595% | -60.136% | -77.281% | -64.712% |
| Carisma Therapeutics Inc. | 29.650% | 26.411% | 2.239% | -83.399% | -56.679% | -98.295% | -97.946% |
| Vivoryon Therapeutics N.V. | 10.900% | -11.359% | -59.196% | -85.179% | -77.289% | -88.879% | -91.488% |
| Moleculin Biotech Inc | 1.530% | - | - | - | - | - | - |